ID   EDITGENE Daudi-FLUC
AC   CVCL_F5U2
SY   Daudi-FLUC
DR   EDITGENE; EDC01580
CC   Population: African; Kenyan.
CC   Characteristics: Growth mode Suspension.
CC   Sequence variation: Gene fusion; HGNC; HGNC:5477; IGH + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGH (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:914; B2M; Simple; p.Met1Ile (c.3G>C); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Gly266Glu (c.797G>A); ClinVar=VCV000161516; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P08659; Photinus pyralis firefly-type luciferase (Note=With optimized codon usage for mammalian expression = Luc2).
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P13249; Streptomyces alboniger pac (PuroR).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): EDITGENE=EDC01580
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D12S391: 17,20
ST   D13S317: 11,12
ST   D16S539: 10,12
ST   D18S51: 16,18
ST   D19S433: 12,14
ST   D21S11: 34,35
ST   D2S1338: 17,24
ST   D2S441: 11,14
ST   D3S1358: 16,18
ST   D5S818: 8,13
ST   D6S1043: 11,20
ST   D7S820: 8,10
ST   D8S1179: 14
ST   FGA: 21,26
ST   Penta D: 10,12
ST   Penta E: 7,9
ST   TH01: 6,7
ST   TPOX: 8,11
ST   vWA: 15,17
DI   NCIt; C27694; EBV-related Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0008 ! Daudi
SX   Male
AG   16Y
CA   Cancer cell line
DT   Created: 25-06-26; Last updated: 25-06-26; Version: 1
//